CIK 0001534969
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
SERA PROGNOSTICS, INC.
Sign in to watch- Ticker
- SERA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 261911522
- Phone
- +1 801-990-0520
- Business address
- 2749 E. PARLEYS WAY, SUITE 200, SALT LAKE CITY, UT, 84109
- Former names
- SERA PROGNOSTICS, INC.
- 4 Open-market sale Chief Scientific Officer sold 1,517 shares at $2.04 ($3,095)
- 4 Open-market sale Chief Financial Officer sold 7,088 shares at an average $1.92 ($13,610)
- 4 Open-market sale Chief Data Officer sold 2,026 shares at $1.96 ($3,971)
- 4 Open-market sale General Counsel sold 3,119 shares at $1.96 ($6,113)
- 4 Open-market sale Chief Information Officer sold 3,360 shares at $1.96 ($6,586)
- 4 Open-market sale Chief Scientific Officer sold 3,038 shares at $1.96 ($5,954)
- 4 Open-market sale Chief Financial Officer sold 674 shares at $1.96 ($1,321)
- 4 Planned sale Director sold 1,560 shares at $1.95 ($3,042)
- 4 Planned sale Chief Information Officer sold 2,000 shares at $2.34 ($4,680)
- 4 Other disposition Director disposed of 30,920 shares (other)
- 4 Planned sale Chief Information Officer sold 2,000 shares at $2.97 ($5,940)
- 4 Planned sale Chief Information Officer sold 2,000 shares at $3.00 ($6,000)
- 4 Open-market sale Chief Executive Officer sold 4,155 shares at $3.31 ($13,753)
- 4 Open-market sale Chief Data Officer sold 1,213 shares at $3.31 ($4,015)
- 4 Open-market sale General Counsel sold 892 shares at $3.31 ($2,953)
- 4 Open-market sale Chief Information Officer sold 616 shares at $3.31 ($2,039)
- 4 Open-market sale Chief Scientific Officer sold 1,332 shares at $3.31 ($4,409)
- 4 Open-market sale Chief Financial Officer sold 873 shares at $3.31 ($2,890)
- 4 Open-market sale Chief Executive Officer sold 28,215 shares at $3.04 ($85,774)
- 4 Open-market sale Chief Financial Officer sold 5,232 shares at $3.04 ($15,905)
Page 3 of 16 · 313 filings